Eric Chen

CEO and co-founder of Injective Labs

Eric Chen, is CEO and co-founder of Injective Protocol. The desire to build a truly decentralized derivatives exchange led him on a journey from hedge funds to eventually being incubated by Binance, the world’s leading digital assets exchange. During this process, Chen learned valuable lessons about how a pragmatic approach to innovation can help companies gain a competitive advantage and succeed in the fast-paced world of tech.  Injective is an open interoperable smart contracts platform optimized for decentralized finance applications.  Prior to Injective Protocol, He was a researcher at Innovating Capital working on trading strategies and protocol Research. Eric Chen attended New York University where he gained a Bachelor of Science - BS, CS . He also holds a Bachelor's degree in Finance from the New York University Stern School of Business. 

More Details